Enrollment has reached 50% in an ongoing study testing whether a PET tracer can reliably measure myelin damage in people with ...

A study found a twofold higher risk of MS for people with myelitis, or spinal cord inflammation, who have multiple lesions on ...

Stock Gains After Enrollment Milestone Reached Shares of Quantum BioPharma (NASDAQ:QNTM) rose 10% in premarket trading on ...

Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum ...

A recent Npj Digital Medicine study assesses the accuracy and effectiveness of artificial intelligence (AI)-based imaging techniques to diagnose multiple sclerosis (MS). Study: A real-world clinical ...

CHICAGO (Reuters) - Brain scans using magnetic resonance imaging may be able to detect signs of multiple sclerosis long before symptoms of the disease appear, U.S. researchers said on Wednesday. They ...

A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests positron emission tomography (PET) brain scans could reveal hidden inflammation ...

Widespread brain inflammation diminishes over time in Long COVID, shifting the clinical focus to emotional regulation.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that patient enrollment in its collaborative multiple sclerosis ...